Limited doses of immunotherapy use in advanced non-small cell lung cancer elderly patients with ECOG of 2 and high PDL-1 expression

The treatment landscape of lung cancer has evolved over the years; the standard of care has shifted from chemotherapy to the use of targeted therapy or immunotherapy (IO) as first-line treatment in patients with advanced non-small cell lung cancer (NSCLC). Breakthroughs were seen in 2015 and 2016 w...

Full description

Bibliographic Details

Main Authors:	Wong, Pui Yee, How, Soon Hin, Hassan, Radhiana, Abdul Azih, Muhammad Naimmuddin
Format:	Article
Language:	en en
Published:	Beijing Hospital and John Wiley & Sons Australia, Ltd. 2021
Subjects:	R Medicine (General)
Online Access:	http://irep.iium.edu.my/93324/7/93324_Limited%20doses%20of%20immunotherapy%20use%20in%20advanced.pdf http://irep.iium.edu.my/93324/13/93324_Limited%20doses%20of%20immunotherapy%20use%20in%20advanced%20non-small%20cell%20lung%20cancer%20elderly%20patients_Scopus.pdf http://irep.iium.edu.my/93324/ https://onlinelibrary.wiley.com/doi/10.1002/agm2.12179
Tags:	Add Tag No Tags, Be the first to tag this record!